Butterbur Petasites hybridus
Also called: petasites, purple butterbur, butter dock, bog rhubarb
A herbaceous perennial native to Europe, southwestern Asia and North Africa (it also grows in parts of North America), named for its large leaves once used to wrap butter. Supplements use root or leaf extracts; the raw plant contains liver-toxic pyrrolizidine alkaloids.
- Category
- Botanical
- Part used
- Root and leaf (extracts)
- Strongest evidence
- B Some positive trials
- Reviewed
- 2026-10-28
Class 2 Moderately studied in people. A 2007 systematic review (Ann Allergy Asthma Immunol) of herbal medicines for allergic rhinitis included 6 double-blind RCTs of Petasites hybridus (butterbur) extract versus placebo or an antihistamine. [3]
Fact-checked 2026-10-28 · How this guide is made
Education, not medical advice. These statements have not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure or prevent any disease, or to replace any medication or medical advice. EUTECNIQ sells no supplements today, and this page links to no product. Supplements can interact with medicines; ask a doctor or pharmacist before use, especially in pregnancy, while breastfeeding, before surgery or for a child.
What research has studied
Grades describe the human evidence in the cited sources, not a recommendation. A means consistent randomized trials; X means good trials found no effect.
BBrain, mood and sleep1 topic
CLungs and airways2 topics
CSeveral areas, whole body or blood1 topic
A consistent trialsB some positive trialsC limited human evidenceD lab or animal onlyX no effect in good trials
| Topic studied | Grade | What the evidence shows |
|---|---|---|
| Migraine frequency in adults and children (root extract) | B | NCCIH reports oral butterbur root extract may reduce migraine frequency. The American Academy of Neurology recommended it in 2012 but stopped in 2015 because of serious safety concerns. [1] |
| Hay fever (allergic rhinitis; leaf extract) | C | Results are mixed: some studies found effects comparable to cetirizine, others found no benefit over placebo for intermittent rhinitis; a systematic review called for more rigorous studies. [2] |
| Asthma | C | Limited evidence: one open trial and a few studies suggesting possible benefit. [2] |
| Other conditions | C | NCCIH states research on other conditions is too limited to draw conclusions. [1] |
Main constituents: Petasins (sesquiterpenes), considered the active constituents [2]; Pyrrolizidine alkaloids (PAs), which can damage the liver and lungs and may cause cancer [1]
Safety and side effects
- Liver (NIH LiverTox)Score CABCDEA: well known causeE: unlikely cause
LiverTox likelihood score C: probable cause of clinically apparent liver injury, possibly caused by contaminants (chapter last updated February 18, …
Details and sources - Pregnancy and breastfeedingNCCIH: PA-containing products should not be used during pregnancy or breastfeeding because they may cause birth defects or liver damage …
1 statement in the profile.
Details and sources - Interactions with medicines2 listed
Medicines in general; Any medicine
Details and sources - Cancer evaluations (IARC, NTP)None found
No IARC or NTP evaluation was found in the lists checked.
Details and sources - FDA new dietary ingredient notifications1 on FDA's list
FDA does not approve dietary supplements. Each entry is one party's filing.
Details and sources - Dose in official monographsNone found
No published information found in the sources checked.
Details and sources
- Pyrrolizidine alkaloids can damage the liver and lungs and may cause cancer. Only products processed to remove PAs and labeled or certified PA-free should be considered. [1]
- PA-free products seem safe orally for up to 16 weeks in several studies, including in children and adolescents, but rare liver injuries have been reported with products labeled PA-free. [1]
- Products containing PAs may not be safe on the skin, because PAs could be absorbed through cuts or scrapes. [1]
- Possible side effects of oral use: belching, diarrhea, drowsiness, rash and stomach upset. [1]
- People allergic to ragweed, chrysanthemums, marigolds or daisies may react to butterbur. People with liver disease should avoid raw extracts containing PAs. [2]
- Pregnancy and breastfeeding: PA-containing products should not be used because they may cause birth defects or liver damage; whether PA-free products are safe is largely unknown. [1]
Interactions
| With | What happens |
|---|---|
| Any medicine | NCCIH advises talking with a health care provider before use if you take any medicine; no specific interacting drugs are named. [1] |
Tell a pharmacist or doctor about every supplement you take. All documented interactions in this hub.
Identity, quality and standardization
Regulatory status
- US: marketed as a dietary supplement (promoted for migraine and hay fever); supplements are not FDA-approved before sale. A professional guideline recommendation for migraine was withdrawn in 2015 over safety concerns. [1]
Safety, quality and supply profile
Fourteen questions a careful buyer, formulator or clinician would ask, each answered only from a cited source (checked 2026-10-29). If our sources do not answer a question, we say so.
Compounds responsible
Compounds the sources name as the main or characteristic actives.
US status
What FDA's published records show. FDA does not approve dietary supplements.
- FDA's published NDI notification list has 1 entry naming Petasites hybridus (NDI 789, a leaf extract, submitted 2013-02-20). Each entry is one party's notification; the list gives the date of FDA's response letter but not what it said. [P4]
Cancer evaluations (IARC and NTP)
Evaluations name the exact material tested, which may differ from a supplement.
Liver (NIH LiverTox)
- LiverTox likelihood score C: probable cause of clinically apparent liver injury, possibly caused by contaminants (chapter last updated February 18, 2019). Preparations processed to remove pyrrolizidine alkaloids do not appear to cause liver injury. [P3]
Interactions with medicines
Alcohol
- No published information found in the sources checked.
Interactions with other herbs and supplements
- No published information found in the sources checked.
Adulteration and substitution
- Contamination: LiverTox reports that, after a commercial butterbur product was authorized in Europe for migraine, isolated cases of cholestatic hepatitis arose; testing suggested some preparations contained detectable pyrrolizidine alkaloids, and some products were withdrawn. [P3]
What a certificate of analysis should cover
Tests a quality specification for this material would include, with the reason for each.
- Identity test or examination of each dietary-ingredient component — US cGMP rule for dietary supplements: at least one appropriate test or examination must verify the identity of any component that is a dietary ingredient (21 CFR 111.75(a)(1)(i)); exemption only through a petition FDA grants (111.75(a)(1)(ii)). [P5]
- Pyrrolizidine alkaloids (e.g. senecionine, integerrimine) — Oral butterbur products must be specially processed to remove pyrrolizidine alkaloids, and testing has found detectable amounts in some preparations. [P3]
- PA-free processing and labeling or certification — NCCIH: only products processed to remove pyrrolizidine alkaloids and labeled or certified PA-free should be considered; rare liver injuries have still been reported with PA-free products. [P1]
Supply and conservation
- No published information found in the sources checked.
Absorption in people
- No published information found in the sources checked.
Formulations studied to change absorption
Human data only.
- No published information found in the sources checked.
Dose in official monographs
As the monograph states it, for its jurisdiction; not personal advice.
- No published information found in the sources checked.
Pregnancy and breastfeeding
- NCCIH: PA-containing products should not be used during pregnancy or breastfeeding because they may cause birth defects or liver damage; whether PA-free products are safe is largely unknown. [P1]
Sources for this profile
- NCCIH. Butterbur: Usefulness and Safety (last updated November 2024), 2024-11. nccih.nih.gov
- Memorial Sloan Kettering Cancer Center. About Herbs: Butterbur (last updated July 12, 2023), 2023-07-12. mskcc.org
- NIH LiverTox (NIDDK). Butterbur (Last Update: February 18, 2019), 2019-02-18. ncbi.nlm.nih.gov
- FDA. Submitted 75-Day Premarket Notifications for New Dietary Ingredients (list dated July 9, 2026), 2026-07-09. fda.gov
- eCFR. 21 CFR 111.75, What must you do to determine whether specifications are met? (up to date as of October 23, 2026), 2026-10-23. ecfr.gov
- IARC Monographs. List of Classifications (retrieved October 29, 2026), 2026-10-29. monographs.iarc.who.int
- National Toxicology Program. Technical Reports (list retrieved October 29, 2026), 2026-10-29. ntp.niehs.nih.gov
Sources
- NCCIH. Butterbur: Usefulness and Safety (last updated November 2024), 2024-11. nccih.nih.gov
- Memorial Sloan Kettering Cancer Center. About Herbs: Butterbur (last updated July 12, 2023), 2023-07-12. mskcc.org
- Guo R, Pittler MH, Ernst E. Herbal medicines for the treatment of allergic rhinitis: a systematic review. Ann Allergy Asthma Immunol 2007;99(6):483-95 (PMID 18219828), 2007-12. pubmed.ncbi.nlm.nih.gov
- A
- Consistent results from several randomized trials or a systematic review of them
- B
- Some positive randomized trials, but small, short, few or inconsistent
- C
- Limited human evidence: single small trials, observational data or mixed results
- D
- Laboratory or animal evidence only; not shown in people
- X
- Well-designed human trials found no meaningful effect
More in botanical: Aloe vera · American ginseng · Amla · Andrographis · Arjuna · Arnica · Aronia (black chokeberry) · Asafoetida · All entries A–Z · How to judge a supplement
Health information notice
These statements have not been evaluated by the Food and Drug Administration. Nothing on this site is intended to diagnose, treat, cure or prevent any disease. The information is for general education only. It is not medical advice and does not replace advice, diagnosis or treatment from a qualified health professional, or any medication a clinician has prescribed.
Do not start, stop or change any medicine, supplement or herbal product because of something you read here. Talk to your doctor or pharmacist first, especially if you are pregnant or breastfeeding, have a medical condition, take any medicines, are preparing for surgery, or are caring for a child. Research findings, traditional uses and safety data are reported as their sources state them; they are not recommendations or claims about any product. If you think you may have a medical emergency, call your doctor or 911 at once.
EUTECNIQ Sciences sells no supplements or health products today and receives nothing from any product or ingredient mentioned on this site; any commercial interest it later has in an ingredient will be stated on that ingredient’s page.